kvmb Chapter 341 has been tampered with.
Chapter 341 has been tampered with.
……
After arriving at the laboratory, Chen Xuan immediately began to simulate using human and medical simulators.
These are just reports of clinical trials, which cannot be reproduced using ordinary testing equipment.
But humans and medical simulators are different. As long as the clinical trial reports are true and effective, very simple simulations can be performed.
Even though this simulation may lack many things, it is just the most basic simulation.
But before we get the medicine, we can only do this first. Maybe we can verify whether the theory is credible.
Just after the program enters the data of the clinical trial,
The human and medical simulators soon experienced simulation errors and were unable to perform normal simulations.
Next, he continued to adjust, enrich, and simulate again and again, but the results were always the same.
"What's going on? Are all these reports wrong?"
"So, these reports are not even feasible in theory?"
"There's only one possibility. Someone modified the report, causing an error."
After many attempts, Chen Xuan frowned slightly.
I have already come to a conclusion in my mind.
That is, there is a problem with the clinical trial report.
And this problem was still artificially modified.
It’s like building blocks. If the most important block is missing and is replaced by other blocks, then it will be impossible to piece the puzzle together no matter how hard you try.
Therefore, the human and medical simulators report errors again and again because this report has been modified.
As for why the clinical trial report needs to be revised?
In fact, the reason is very simple, that is, there are problems with the clinical trials.
In order to cover up the problems, some people will modify the data to conceal them.
This type of modification is essentially impossible to detect, and can only be discovered through simulations by humans and medical simulators.
If you want to discover it, you can only do the experiment from beginning to end, and you may find the problem.
It’s no wonder that Chen Xuan always found something unusual in this report. It turns out that his intuition was right.
"If Pfizer doesn't find it, the consequences will be serious."
"I really wish I could get this medicine so I could get tested right now. I could find out what the problem is."
Chen Xuan now hopes more and more that Luo Shiyun can get this medicine.
As long as he could get the medicine, even if it was just a pill, he would be able to analyze the problem.
But even if he discovered the problem, he would not tell Pfizer. He would not make his contribution in vain.
The reason I want to do the test and analysis is simply out of curiosity.
And if Pfizer fails to analyze the problem, the consequences will be terrible.
Whether the problem is discovered after the acquisition or after the listing, the consequences will be very serious. The later the discovery, the greater the loss.
At that time, if this bomb explodes, Pfizer may be stunned.
The company Elsilan hid the problems so much that it even modified the reports to cover up the problems in the clinical trials.
This shows that the problem is so serious that they dare not expose it. Instead, they want to cash out as soon as possible, which is why they need to revise this report.
If Pfizer fails to discover the problem, the blame will be shifted to Pfizer. As for the Elsheland team, they might just get the money and run away.
After thinking of this possibility, Chen Xuan couldn't help but smile.
He didn't expect that his momentary curiosity would lead to such a huge unexpected gain.
This matter is becoming more and more interesting.
……
A few days later!
Today, Antai Pharmaceutical Group is once again bustling with activity.
This is because the phase III clinical trial of a special drug for lung cancer is about to end today.
Once the Phase III clinical trial is completed, it means that the effective drug for lung cancer will be officially launched on the market soon.
Therefore, countless reporters once again focused their attention on Antai Pharmaceutical Group, and it also attracted the attention of countless patients, who are all looking forward to the early launch of this special drug for lung cancer.
This new drug has become the hope, or even the only hope, for most lung cancer patients to survive.
Most importantly, the price of lung cancer-specific drugs is relatively cheap, which makes countless patients look forward to the launch of new drugs day and night.
At the same time, CCTV also came to interview and help promote the special medicine for lung cancer.
So, this day was really lively.
The huge lobby was already full of people.
"Today marks the end of the Phase III clinical trial of a lung cancer drug."
"From the first day of the clinical trial to today, a lot has happened, and there have been many twists and turns."
"Fortunately, all the problems have been resolved. The lung cancer drug has been proven to be effective and safe in phase III clinical trials, and multiple indications have been discovered."
Chen Xuan stood on the podium and announced to the audience, "The results of all the tests have exceeded expectations, proving that this lung cancer drug is safe and effective, suitable for large-scale application."
As soon as the words fell, the whole audience suddenly boiled over.
Although everyone who participated in this event today had already known the news in advance,
But when I heard him say it himself, I still felt extremely excited.
Because the lung cancer specific drug is China's first anti-cancer drug and the only specific drug that can cure lung cancer.
This alone is enough to excite countless Chinese people, and the most anticipated are lung cancer patients, as this is their only hope of survival.
"Mr. Chen, the Phase III clinical trial has ended."
"Patients participating in clinical trials have also proven that this drug is effective and can definitely cure lung cancer."
"So when will this lung cancer drug be officially available? This is news countless patients are waiting for. Can you share some information?"
At this time, CCTV host Bingbing also asked a question.
This issue, which is also the focus of today, is the time when the special medicine for lung cancer will be officially launched on the market.
Because countless lung cancer patients are waiting for this day, they are extremely eager to see effective drugs for lung cancer come to the market.
After all, patients who participated in clinical trials already have a chance to survive, but other lung cancer patients have not yet received treatment with lung cancer-specific drugs.
If they cannot obtain effective drugs for lung cancer in time, their lives will always be in danger, especially for patients with advanced lung cancer. Every day of delay increases the risk.
"A specific drug for lung cancer has been approved for marketing."
"All qualifications have been successfully obtained and can be put on the market legally and compliantly."
"Our production department has officially started producing new drugs, which are available to major hospitals at any time. We will also conduct clinical trials in urban areas and continue to monitor patient usage."
Chen Xuan answered this question very directly.
This news also excited countless people.
After all, the specific drug for lung cancer has been approved for marketing and is currently in production, which means it can enter the market at any time.
“As for when it will be launched?”
"I think this question should be answered by Director Mo Xuefeng."
"Let him introduce this issue. He should be able to answer what you want to know."
At this time, Chen Xuan suddenly said.
Instead of answering himself, he invited Mo Xuefeng to come on stage.
After all, Mo Xuefeng is the main person in charge of this matter, and he should indeed be allowed to introduce himself.
"Hello, I'm Mo Xuefeng from the Medical Insurance Bureau."
"Regarding the effective drug for lung cancer, our Medical Insurance Bureau and Antai Pharmaceutical Group have reached the best possible cooperation after many exchanges."
"First of all, I would like to express my sincere gratitude to Mr. Chen and Antai Pharmaceutical Group for their support. They have worked hard to develop a lung cancer drug that has given hope to countless patients."
"At that time, I also want to thank Mr. Chen for his understanding and support of medical insurance. Without his understanding, lung cancer drugs would not be included in medical insurance and benefit so many patients."
Mo Xuefeng stood on the podium.
This time, he also praised Chen Xuan and Antai Pharmaceutical Group without hesitation.
On behalf of the China Medical Insurance Bureau, he affirmed the latter's contribution, and it was a public affirmation.
Saying this in private and publicly praising it have completely different meanings. The former only represents him, while the latter represents the attitude of the Medical Insurance Bureau and even the entire Chinese government.
Obviously, the Chinese government is also very satisfied with the pricing of the special medicine for lung cancer.
The price of this medicine is not cheap, but compared with the sky-high prices of similar drugs, it can be considered extremely cost-effective.
The most important thing is that the price of foreign drugs is four times that of the domestic market, which deserves more recognition from the Chinese government.
After all, this is Chen Xuan's support for the country, which is why he came up with such a huge difference in pricing between domestic and foreign markets. The country will naturally see and remember this support.
……